Search Results - "Hack SP"

Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma.

Authors: Yopp A Chen M Cheng AL et al.

Source: Journal of hepatology [J Hepatol] 2026 Jun; Vol. 84 (6), pp. 1102-1111. Date of Electronic Publication: 2026 Jan 22.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE

Molecular subtypes of hepatocellular carcinoma linked to liver cell lineages and clinical outcomes of combination immunotherapy.

Authors: Wang Y Guan Y Abbas AR et al.

Source: Cell reports. Medicine [Cell Rep Med] 2025 Dec 16; Vol. 6 (12), pp. 102473. Date of Electronic Publication: 2025 Nov 28.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework.

Authors: Shemesh CS Chan P Marchand M et al.

Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2023 Sep; Vol. 114 (3), pp. 644-651. Date of Electronic Publication: 2023 Jun 02.

Publication Type: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial.

Authors: Macarulla T Ren Z Chon HJ et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Feb 10; Vol. 43 (5), pp. 545-557. Date of Electronic Publication: 2024 Oct 18.

Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b-2, study.

Authors: Finn RS Ryoo BY Hsu CH et al.

Source: The Lancet. Oncology [Lancet Oncol] 2025 Feb; Vol. 26 (2), pp. 214-226. Date of Electronic Publication: 2025 Jan 21.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Multicenter Study; Clinical Trial, Phase II

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial - Authors' reply.

Authors: Chow PKH Hack SP Spahn JH et al.

Source: Lancet (London, England) [Lancet] 2024 Aug 17; Vol. 404 (10453), pp. 657-658.

Publication Type: Letter; Comment

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer.

Authors: Hack SP Verret W Mulla S et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2021 Jul 31; Vol. 13, pp. 17588359211036544. Date of Electronic Publication: 2021 Jul 31 (Print Publication: 2021).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.

Authors: Hack SP Zhu AX Wang Y

Source: Frontiers in immunology [Front Immunol] 2020 Nov 05; Vol. 11, pp. 598877. Date of Electronic Publication: 2020 Nov 05 (Print Publication: 2020).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.

Authors: Qin S Chen M Cheng AL et al.

Corporate Authors: Qin S Chen M Cheng AL et al.

Source: Lancet (London, England) [Lancet] 2023 Nov 18; Vol. 402 (10415), pp. 1835-1847. Date of Electronic Publication: 2023 Oct 20.

Publication Type: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Atezolizumab: an investigational agent for the treatment of biliary tract cancer.

Authors: Hack SP Zhu AX

Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2021 Oct; Vol. 30 (10), pp. 1007-1015. Date of Electronic Publication: 2021 Sep 01.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE

A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.

Authors: Bendell JC Hochster H Hart LL et al.

Source: The oncologist [Oncologist] 2017 Mar; Vol. 22 (3), pp. 264-271. Date of Electronic Publication: 2017 Feb 16.

Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Population pharmacokinetics and dosing implications for cobimetinib in patients with solid tumors.

Authors: Han K Jin JY Marchand M et al.

Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2015 Nov; Vol. 76 (5), pp. 917-24. Date of Electronic Publication: 2015 Sep 13.

Publication Type: Comparative Study; Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia.

Authors: Tran G Hack SP Kerr A et al.

Source: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2013 Sep; Vol. 9 (3), pp. 239-48. Date of Electronic Publication: 2012 Dec 21.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101241430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-7563 (Electronic) Linking ISSN: 17437555 NLM ISO Abbreviation: Asia Pac J Clin Oncol Subsets: MEDLINE

Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer.

Authors: Bendell JC Ervin TJ Gallinson D et al.

Source: Clinical colorectal cancer [Clin Colorectal Cancer] 2013 Sep; Vol. 12 (3), pp. 218-22. Date of Electronic Publication: 2013 Jun 27.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study.

Authors: Lee MS Ryoo BY Hsu CH et al.

Corporate Authors: Lee MS Ryoo BY Hsu CH et al.

Source: The Lancet. Oncology [Lancet Oncol] 2020 Jun; Vol. 21 (6), pp. 808-820.

Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation.

Authors: Hack SP Spahn J Chen M et al.

Source: Future oncology (London, England) [Future Oncol] 2020 May; Vol. 16 (15), pp. 975-989. Date of Electronic Publication: 2020 Apr 30.

Publication Type: Clinical Trial Protocol; Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence.

Authors: Foley PA Quirk C Sullivan JR et al.

Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2010 Oct; Vol. 24 (10), pp. 1135-43.

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE

Serotonergic and nonserotonergic dorsal raphe neurons are pharmacologically and electrophysiologically heterogeneous.

Authors: Marinelli S Schnell SA Hack SP et al.

Source: Journal of neurophysiology [J Neurophysiol] 2004 Dec; Vol. 92 (6), pp. 3532-7. Date of Electronic Publication: 2004 Jul 14.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

Journal Info: Publisher: American Physiological Society Country of Publication: United States NLM ID: 0375404 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0022-3077 (Print) Linking ISSN: 00223077 NLM ISO Abbreviation: J Neurophysiol Subsets: MEDLINE

Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.

Authors: Vaughan CW Bagley EE Drew GM et al.

Source: British journal of pharmacology [Br J Pharmacol] 2003 May; Vol. 139 (2), pp. 362-7.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print Cited Medium: Print ISSN: 0007-1188 (Print) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE

Dynamic modulation of excitation and inhibition during stimulation at gamma and beta frequencies in the CA1 hippocampal region.

Authors: Bracci E Vreugdenhil M Hack SP et al.

Source: Journal of neurophysiology [J Neurophysiol] 2001 Jun; Vol. 85 (6), pp. 2412-22.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Physiological Society Country of Publication: United States NLM ID: 0375404 Publication Model: Print Cited Medium: Print ISSN: 0022-3077 (Print) Linking ISSN: 00223077 NLM ISO Abbreviation: J Neurophysiol Subsets: MEDLINE